Commission Regulation (EC) No 1805/2006 of 7 December 2006 amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards thiamphenicol, fenvalerate and meloxicam   (Text with EEA relevance)
Date: 2006-12-07
Institutions: European Commission
Subjects: animal product, foodstuff, foodstuffs legislation, veterinary drug, waste

L 343/66

EN

Official Journal of the European Union

8.12.2006

COMMISSION REGULATION (EC) No 1805/2006

of 7 December 2006

amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure
for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of
animal origin, as regards thiamphenicol, fenvalerate and meloxicam

(Text with EEA relevance)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty
Community,

establishing the European

Having regard to Council Regulation (EEC) No 2377/90 of 26
June 1990 laying down a Community procedure for the estab-
lishment of maximum residue limits of veterinary medicinal
products in foodstuffs of animal origin (1), and in particular
Article 2 thereof,

Having regard to the opinions of
the European Medicines
Agency formulated by the Committee for Medicinal Products
for Veterinary Use,

Whereas:

(1)

(2)

All pharmacologically active substances used in the
Community in veterinary medicinal products intended
for
should be evaluated in
accordance with Regulation (EEC) No 2377/90.

food-producing animals

fat,

liver, kidney and milk as well as

The substance thiamphenicol is included in Annex I to
Regulation (EEC) No 2377/90 for bovine species for
muscle,
for
liver and kidney,
chicken for muscle, skin and fat,
excluding animals which produce
for human
eggs
consumption. Thiamphenicol is also included in Annex
III to that Regulation for porcine species for muscle, skin
and fat, liver and kidney. Following examination of the
information provided by the applicant
for the estab-
lishment of final maximum residues limits for thiam-
phenicol in porcine species, it is considered appropriate
in Annex I to
to modify the entry of thiamphenicol
food-producing
Regulation (EEC) No 2377/90 to all
species for muscle, fat, liver, kidney and milk, excluding
animals which produce eggs for human consumption.
The maximum residue limits for fat,
liver and kidney
should not apply to fin fish.

(3)

The substance fenvalerate is included in Annex III to
Regulation (EEC) No 2377/90 for bovine for muscle,
fat, liver, kidney and milk. Those provisional maximum
residue limits expire on 1 July 2006. Following exami-

(1) OJ L 224, 18.8.1990, p. 1. Regulation as

(EC) No 1729/2006 (OJ

last amended by
L 325,

Commission Regulation
24.11.2006, p. 6).

nation of the information provided by the applicant for
the establishment of final maximum residues for fenva-
lerate limits for bovine species,
it is considered appro-
priate to include fenvalerate in Annex I to Regulation
(EEC) No 2377/90 for bovine species for muscle, fat,
liver, kidney and milk.

The substance meloxicam is included in Annex I
to
Regulation (EEC) No 2377/90 for bovine, porcine and
equidae species for muscle, liver and kidney as well as for
bovine species for milk. Following examination of an
application for the establishment of maximum residues
limits for meloxicam in rabbits and caprine species for
milk, it is considered appropriate to modify the entry of
meloxicam in that Annex for rabbits and caprine species
for muscle, liver and kidney as well as to caprine species
for milk.

Regulation (EEC) No 2377/90 should therefore be
amended accordingly.

this Regulation in order

An adequate period should be allowed before the
to enable
applicability of
Member States to make any adjustment which may be
necessary in the light of this Regulation to the author-
isations
to place the veterinary medicinal products
concerned on the market which have been granted in
accordance with Directive 2001/82/EC of the European
Parliament and of the Council of 6 November 2001 on
the Community code relating to veterinary medicinal
products (2) to take account of the provisions of this
Regulation.

The measures provided for in this Regulation are in
accordance with
Standing
the
the
Committee on Veterinary Medicinal Products,

opinion

of

(4)

(5)

(6)

(7)

HAS ADOPTED THIS REGULATION:

Article 1

Annex I
accordance with the Annex to this Regulation.

to Regulation (EEC) No 2377/90 is amended in

(2) OJ L 311, 28.11.2001, p. 1. Directive as amended by Directive

2004/28/EC (OJ L 136, 30.4.2004, p. 58).

8.12.2006

EN

Official Journal of the European Union

L 343/67

This Regulation shall enter into force on the third day following its publication in the Official Journal of the
European Union.

Article 2

It shall apply from 8 February 2007.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 7 December 2006.

For the Commission

Günter VERHEUGEN
Vice-President

L 343/68

EN

Official Journal of the European Union

8.12.2006

s
e
u
s
s
i
t

t
e
g
r
a
T

s
L
R
M

s
e
i
c
e
p
s

l
a
m
n
A

i

e
u
d
i
s
e
r

r
e
k
r
a
M

)
s
(
e
c
n
a
t
s
b
u
S

e
v
i
t
c
a

y
l
l
a
c
i
g
o

l

o
c
a
m
r
a
h
P

s
d
n
u
o
p
m
o
c

d
e
t
a
l
e
r

d
n
a

l

o
c
i
n
e
f
r
o
l
F

.

.

5
2
1

.

X
E
N
N
A

:
)
d
e
x
i
f

n
e
e
b

e
v
a
h

s
t
i

m

i
l

e
u
d
i
s
e
r

m
u
m
i
x
a
m

h
c
i
h
w

r
o
f

s
e
c
n
a
t
s
b
u
s

e
v
i
t
c
a

l

y
l
l
a
c
i
g
o
o
c
a
m
r
a
h
p

f
o

t
s
i
L
(

0
9
/
7
7
3
2

o
N

)

C
E
E
(

n
o
i
t
a
l
u
g
e
R

o
t

I

x
e
n
n
A

n

i

d
e
t
r
e
s
n

i

s
i

e
c
n
a
t
s
b
u
s

i

g
n
w
o

l
l

o
f

e
h
T

s
t
n
e
g
a

s
u
o
i
t
c
e
f
n
i
-
i
t
n
A

.

1

i

s
c
i
t
o
b
i
t
n
A

.

2
1

.

)
2
(

e
l
c
s
u
M

)
3
(

t
a
F

r
e
v
i
L

y
e
n
d
K

i

k

l
i

M

g
k
/
g

g
k
/
g

g
k
/
g

g
k
/
g

g
k
/
g

μ

μ

μ

μ

μ

0
5

0
5

0
5

0
5

0
5

)
1
(

s
e
i
c
e
p
s

g
n
i
c
u
d
o
r
p

d
o
o
f

l
l

A

l

o
c
i
n
e
h
p
m
a
i
h
T

l

o
c
i
n
e
h
p
m
a
i
h
T

‘

.

h
s
i
f

n
i
f

o
t

y
l
p
p
a

t
o
n

o
d

y
e
n
d
k

i

d
n
a

r
e
v
i
l

,
t
a
f

r
o
f

s
L
R
M

,

n
o
i
t
p
m
u
s
n
o
c

n
a
m
u
h

r
o
f

d
e
c
u
d
o
r
p

e
r
a

s
g
g
e

h
c
i
h
w

m
o
r
f

s
l
a
m
n
a

i

n

i

e
s
u

r
o
f

t
o
N

’

.

”

“

s
n
o
i
t
r
o
p
o
r
p

l
a
r
u
t
a
n

n

i

t
a
f

d
n
a

i

n
k
s

o
t

s
e
t
a
l
e
r

L
R
M

s
i
h
t

s
e
i
c
e
p
s

y
r
t
l
u
o
p

d
n
a

e
n
i
c
r
o
p

.

”

s
n
o
i
t
r
o
p
o
r
p

l
a
r
u
t
a
n

n

i

i

n
k
s

d
n
a

e
l
c
s
u
m

o
t

s
e
t
a
l
e
r

e
l
c
s
u
m

h
s
i
f

n
i
f

“

r
o
F

r
o
F

)
1
(

)
2
(

)
3
(

s
e
u
s
s
i
t

t
e
g
r
a
T

s
L
R
M

s
e
i
c
e
p
s

l
a
m
n
A

i

e
u
d
i
s
e
r

r
e
k
r
a
M

)
s
(
e
c
n
a
t
s
b
u
S

e
v
i
t
c
a

y
l
l
a
c
i
g
o

l

o
c
a
m
r
a
h
P

i

s
d
o
r
h
t
e
r
y
P

.

.

3
2
2

.

s
e
t
i
s
a
r
a
p
o
t
c
e

t
s
n
i
a
g
a

g
n
i
t
c
a

s
t
n
e
g
A

.

2
2

.

s
t
n
e
g
a

c
i
t
i
s
a
r
a
p
-
i
t
n
A

.

2

s
e
u
s
s
i
t

t
e
g
r
a
T

s
L
R
M

s
e
i
c
e
p
s

l
a
m
n
A

i

e
u
d
i
s
e
r

r
e
k
r
a
M

)
s
(
e
c
n
a
t
s
b
u
S

e
v
i
t
c
a

y
l
l
a
c
i
g
o

l

o
c
a
m
r
a
h
P

s
t
n
e
g
a

y
r
o
t
a
m
m
a
l
f
n
i
-
i
t
n
a

i

l
a
d
o
r
e
t
s
-
n
o
N

s
e
v
i
t
a
v
i
r
e
d

m
a
c
i
x
O

.

.

1
4

.

.

4
1
4

.

e
l
c
s
u
M

y
e
n
d
K

i

e
l
c
s
u
M

r
e
v
i
L

r
e
v
i
L

y
e
n
d
K

i

’

k

l
i

M

g
k
/
g

g
k
/
g

g
k
/
g

g
k
/
g

g
k
/
g

g
k
/
g

g
k
/
g

μ

μ

μ

μ

μ

μ

μ

0
2

5
6

5
6

0
2

5
6

5
6

5
1

e
n
i
r
p
a
c

,
e
n
i
v
o
B

t
i
b
b
a
r

,
e
a
d
u
q
e

i

,
e
n
i
c
r
o
P

m
a
c
i
x
o
l
e
M

m
a
c
i
x
o
l
e
M

‘

e
l
c
s
u
M

r
e
v
i
L

t
a
F

y
e
n
d
K

i

’

k

l
i

M

g
k
/
g

g
k
/
g

g
k
/
g

g
k
/
g

g
k
/
g

μ

μ

μ

μ

μ

5
2

0
5
2

5
2

5
2

0
4

e
n
i
v
o
B

R
S

d
n
a

S
R

,

S
S

,

R
R

f
o

m
u
s
(

e
t
a
r
e
l
a
v
n
e
F

)
s
r
e
m
o
s
i

e
t
a
r
e
l
a
v
n
e
F

‘

s
t
n
e
g
a

y
r
o
t
a
m
m
a
l
f
n
i
-
i
t
n
A

.

4